Corvus Pharmaceuticals, Inc.
USD14.51
+0.03 (+0.21%)
CEO
Richard A. Miller
IPO Date
2016-03-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.53
Prev. Close
$14.48
Day Low
$14.30
Day High
$14.71
52W Low
$3.71
52W High
$26.95
Market Cap
$1.22B
Volume
0.14M
| -5.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -69.9% | -59.3% | 0.04 | 4.07 | -3.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -73.6% | -60.5% | 0.05 | 4.06 | -1.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -44.5% | -39.5% | 0.04 | 7.36 | -2.3 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -8.3% | -7.0% | 0.03 | 3.73 | -17.5 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -65.6% | -55.8% | 0.04 | 7.76 | -3.4 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -42.5% | -39.7% | 0.00 | 14.51 | -2.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -65.6% | -58.7% | 0.00 | 9.06 | -3.8 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -27.4% | -26.0% | 0.00 | 18.36 | -6.1 |
| -12.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -14.2% | -12.6% | 0.01 | 8.29 | -15.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -10.0% | -8.9% | 0.01 | 8.91 | -9.7 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 30.8% | 25.6% | 0.02 | 4.90 | 3.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -37.2% | -17.6% | 0.03 | 1.54 | -7.5 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -324.1% | -68.4% | 0.03 | 0.92 | -2.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -8.3% | -6.6% | 0.01 | 3.62 | -6.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -17.1% | -14.2% | 0.03 | 3.40 | -4.0 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -17.2% | -14.6% | 0.04 | 4.07 | -3.2 |